Home/Filings/4/0001415889-24-026723
4//SEC Filing

Evans Terry L 4

Accession 0001415889-24-026723

CIK 0001211583other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 5:14 PM ET

Size

6.1 KB

Accession

0001415889-24-026723

Insider Transaction Report

Form 4
Period: 2024-11-13
Evans Terry L
Chief Commercial Officer
Transactions
  • Award

    Stock Options

    2024-11-13$4.23/sh+150,000$634,500150,000 total
    Exercise: $4.23From: 2025-11-13Exp: 2034-11-13Common Shares (150,000 underlying)
Footnotes (2)
  • [F1]On November 13, 2024,Terry Evans was granted incentive stock options to purchase 150,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
  • [F2]One-third of the shares subject to this option may be exercised as of November 13, 2025 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date until all shares have vested.

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1
  • filerCIK 0002043317

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:14 PM ET
Size
6.1 KB